Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)

Ironwood Pharmaceuticals' (IRWD) quarterly Liabilities from Discontinued Operations came in at 15739000.0 in Q4 2018.

Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018) Analysis & Trends

Ironwood Pharmaceuticals has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting 15739000.0 for Q4 2018.

  • Liabilities from Discontinued Operations for Q4 2018 came in at 15739000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was 15739000.0 (changed N/A YoY), and the FY2018 annual result was 15739000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations came in at 15739000.0 for Q4 2018 at Ironwood Pharmaceuticals.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 15739000.0 in Q4 2018 to a low of 15739000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Ironwood Pharmaceuticals 526.31 Mn 305.84 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 15.74 Mn
Dec 31, 2018 15.74 Mn